Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections
- PMID: 34777353
- PMCID: PMC8586491
- DOI: 10.3389/fimmu.2021.741218
Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections
Abstract
The global outbreak of the SARS-Cov-2 virus in 2020 has killed millions of people worldwide and forced large parts of the world into lockdowns. While multiple vaccine programs are starting to immunize the global population, there is no direct cure for COVID-19, the disease caused by the SARS-Cov-2 infection. A common symptom in patients is a decrease in T cells, called lymphopenia. It is as of yet unclear what the exact role of T cells are in the immune response to COVID-19. The research so far has mainly focused on the involvement of classical αβ T cells. However, another subset of T cells called γδ T cells could have an important role to play. As part of the innate immune system, γδ T cells respond to inflammation and stressed or infected cells. The γδ T cell subset appears to be particularly affected by lymphopenia in COVID-19 patients and commonly express activation and exhaustion markers. Particularly in children, this subset of T cells seems to be most affected. This is interesting and relevant because γδ T cells are more prominent and active in early life. Their specific involvement in this group of patients could indicate a significant role for γδ T cells in this disease. Furthermore, they seem to be involved in other viral infections and were able to kill SARS infected cells in vitro. γδ T cells can take up, process and present antigens from microbes and human cells. As e.g. tumour-associated antigens are presented by MHC on γδ T cells to classical T-cells, we argue here that it stands to reason that also viral antigens, such as SARS-Cov-2-derived peptides, can be presented in the same way. γδ T cells are already used for medical purposes in oncology and have potential in cancer therapy. As γδ T cells are not necessarily able to distinguish between a transformed and a virally infected cell it could therefore be of great interest to investigate further the relationship between COVID-19 and γδ T cells.
Keywords: COVID-19; SARS-Cov-2; T cells; gamma-delta T cell; lymphopenia.
Copyright © 2021 von Massow, Oh, Lam and Gustafsson.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Defying convention in the time of COVID-19: Insights into the role of γδ T cells.Front Immunol. 2022 Aug 11;13:819574. doi: 10.3389/fimmu.2022.819574. eCollection 2022. Front Immunol. 2022. PMID: 36032159 Free PMC article. Review.
-
Making a case for using γδ T cells against SARS-CoV-2.Crit Rev Microbiol. 2020 Nov;46(6):689-702. doi: 10.1080/1040841X.2020.1822279. Epub 2020 Oct 7. Crit Rev Microbiol. 2020. PMID: 33023358 Review.
-
Single-Cell RNAseq Profiling of Human γδ T Lymphocytes in Virus-Related Cancers and COVID-19 Disease.Viruses. 2021 Nov 3;13(11):2212. doi: 10.3390/v13112212. Viruses. 2021. PMID: 34835019 Free PMC article.
-
Myeloid-like γδ T cell subset in the immune response to an experimental Rift Valley fever vaccine in sheep.Vet Immunol Immunopathol. 2021 Mar;233:110184. doi: 10.1016/j.vetimm.2021.110184. Epub 2021 Jan 8. Vet Immunol Immunopathol. 2021. PMID: 33454621
-
The phenotypic changes of γδ T cells in COVID-19 patients.J Cell Mol Med. 2020 Oct;24(19):11603-11606. doi: 10.1111/jcmm.15620. Epub 2020 Aug 30. J Cell Mol Med. 2020. PMID: 32864865 Free PMC article.
Cited by
-
Adaptive immune cells are necessary for SARS-CoV-2-induced pathology.Sci Adv. 2024 Jan 5;10(1):eadg5461. doi: 10.1126/sciadv.adg5461. Epub 2024 Jan 3. Sci Adv. 2024. PMID: 38170764 Free PMC article.
-
Bridging the Gap: Can COVID-19 Research Help Combat African Swine Fever?Viruses. 2023 Sep 15;15(9):1925. doi: 10.3390/v15091925. Viruses. 2023. PMID: 37766331 Free PMC article. Review.
-
Airway Epithelial-Derived Immune Mediators in COVID-19.Viruses. 2023 Jul 29;15(8):1655. doi: 10.3390/v15081655. Viruses. 2023. PMID: 37631998 Free PMC article. Review.
-
T cells in health and disease.Signal Transduct Target Ther. 2023 Jun 19;8(1):235. doi: 10.1038/s41392-023-01471-y. Signal Transduct Target Ther. 2023. PMID: 37332039 Free PMC article. Review.
-
Identification of a potential novel biomarker in intervertebral disk degeneration by bioinformatics analysis and experimental validation.Front Immunol. 2023 May 30;14:1136727. doi: 10.3389/fimmu.2023.1136727. eCollection 2023. Front Immunol. 2023. PMID: 37325631 Free PMC article.
References
-
- Cheng MH, Krieger JM, Xiang Y, Kaynak B, Shi Y, Arditi M, et al. . Impact of New Variants on SAR-CoV-2 Infectivity and Neutralization: A Molecular Assessment of the Alterations in the Spike-Host Protein Interactions. (2021). Available at: https://ssrn.com/abstract=3907841/.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
